SCHEMBL11099529

SCHEMBL11099529

O=C(C(=Cc1ccc(Cl)cc1)CN1C(=O)c2ccccc2C1=O)c1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 1/20 0.48
CA9 Q16790 1/20 0.48
RECQL P46063 1/20 0.47
CES2 O00748 1/20 0.44
CES1 P23141 1/20 0.44
SMN1; SMN2 Q16637 3/20 0.43
ALDH1A1 P00352 2/20 0.42
KMT2A Q03164 3/20 0.42
MEN1 O00255 2/20 0.42
NPC1 O15118 2/20 0.41
GSK3B P49841 1/20 0.41
TDP1 Q9NUW8 2/20 0.41
MAOB P27338 1/20 0.40
LMNA P02545 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
MAPT P10636 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
HTT P42858 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20415259 0.78 OPRK1 (0.46) CES2CES1SMN1; SMN2ALDH1A1KMT2A
SCHEMBL29073232 0.78 CES2 (0.55) CES2CES1SMN1; SMN2ALDH1A1KMT2A
SCHEMBL20415346 0.77 NTSR1 (0.45) CES2CES1ALDH1A1KMT2AMEN1
SCHEMBL20415230 0.76 CES2 (0.53) CES2CES1SMN1; SMN2ALDH1A1KMT2A
SCHEMBL20415250 0.75 SMN1; SMN2 (0.47) SMN1; SMN2ALDH1A1KMT2ANPC1TDP1
SCHEMBL20415341 0.75 OPRK1 (0.48) CES2CES1SMN1; SMN2ALDH1A1TDP1
SCHEMBL20415256 0.73 EGFR (0.49) CES2CES1SMN1; SMN2ALDH1A1KMT2A
SCHEMBL5824232 0.72 POLB (0.59) CA12CA9SMN1; SMN2ALDH1A1KMT2A
SCHEMBL26665153 0.71 CES2 (0.57) CES2CES1SMN1; SMN2ALDH1A1KMT2A
SCHEMBL29293530 0.70 ALDH1A1 (0.46) CES2CES1SMN1; SMN2ALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0045520-B1 PYRIMIDO-(4,5-D)(2)-BENZAZEPINES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) 1984-06-20 EP disclosed